122 related articles for article (PubMed ID: 16242529)
1. Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.
Hou G; Dick R; Abrams GD; Brewer GJ
J Lab Clin Med; 2005 Nov; 146(5):299-303. PubMed ID: 16242529
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
Hou G; Dick R; Zeng C; Brewer GJ
Transl Res; 2006 Dec; 148(6):309-14. PubMed ID: 17162252
[TBL] [Abstract][Full Text] [Related]
3. Tetrathiomolybdate is effective in a mouse model of arthritis.
McCubbin MD; Hou G; Abrams GD; Dick R; Zhang Z; Brewer GJ
J Rheumatol; 2006 Dec; 33(12):2501-6. PubMed ID: 17143984
[TBL] [Abstract][Full Text] [Related]
4. Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice.
Osman AM; Nemnem MM; Abou-Bakr AA; Nassier OA; Khayyal MT
Food Chem Toxicol; 2009 Oct; 47(10):2425-30. PubMed ID: 19577608
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
Brewer GJ; Dick R; Ullenbruch MR; Jin H; Phan SH
J Inorg Biochem; 2004 Dec; 98(12):2160-7. PubMed ID: 15541506
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
Hou G; Dick R; Zeng C; Brewer GJ
Transl Res; 2007 May; 149(5):260-4. PubMed ID: 17466925
[TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
[TBL] [Abstract][Full Text] [Related]
9. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
Khan MK; Mamou F; Schipper MJ; May KS; Kwitny A; Warnat A; Bolton B; Nair BM; Kariapper MS; Miller M; Brewer G; Normolle D; Merajver SD; Teknos TN
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):333-8. PubMed ID: 16549755
[TBL] [Abstract][Full Text] [Related]
10. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.
Li L; Takemura G; Li Y; Miyata S; Esaki M; Okada H; Kanamori H; Khai NC; Maruyama R; Ogino A; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2006 Jan; 113(4):535-43. PubMed ID: 16449733
[TBL] [Abstract][Full Text] [Related]
11. Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression.
Neilan TG; Jassal DS; Scully MF; Chen G; Deflandre C; McAllister H; Kay E; Austin SC; Halpern EF; Harmey JH; Fitzgerald DJ
Eur Heart J; 2006 May; 27(10):1251-6. PubMed ID: 16624831
[TBL] [Abstract][Full Text] [Related]
12. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
Brewer GJ; Dick R; Zeng C; Hou G
J Inorg Biochem; 2006 May; 100(5-6):927-30. PubMed ID: 16321443
[TBL] [Abstract][Full Text] [Related]
13. Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia?
Silber JH
Nat Clin Pract Oncol; 2004 Nov; 1(1):16-7. PubMed ID: 16264791
[No Abstract] [Full Text] [Related]
14. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice.
Riad A; Bien S; Westermann D; Becher PM; Loya K; Landmesser U; Kroemer HK; Schultheiss HP; Tschöpe C
Cancer Res; 2009 Jan; 69(2):695-9. PubMed ID: 19147586
[TBL] [Abstract][Full Text] [Related]
15. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
Bertilaccio MT; Grioni M; Sutherland BW; Degl'Innocenti E; Freschi M; Jachetti E; Greenberg NM; Corti A; Bellone M
Prostate; 2008 Jul; 68(10):1105-15. PubMed ID: 18437689
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
Liu L; Shi R; Shi Q; Cheng Y; Huo Y
Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050
[TBL] [Abstract][Full Text] [Related]
17. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
18. Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice.
Askari FK; Dick R; Mao M; Brewer GJ
Exp Biol Med (Maywood); 2004 Sep; 229(8):857-63. PubMed ID: 15337842
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model.
Cox C; Merajver SD; Yoo S; Dick RD; Brewer GJ; Lee JS; Teknos TN
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):781-5. PubMed ID: 12874082
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
Hou G; Abrams GD; Dick R; Brewer GJ
Transl Res; 2008 Nov; 152(5):239-44. PubMed ID: 19010295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
